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Pemphigus represents a group of autoimmune blistering dis-
eases caused by autoantibodies against desmogleins (Dsgs), 
a class of desmosomal cadherins. Recently, several pemphi-
gus patients only with desmocollin (Dsc) 3-specific anti-
bodies have been reported. Here, we report a case of pem-
phigus herpetiformis (PH), where only anti-Dsc3-specific an-
tibodies but not anti-Dsg antibodies were detected. A 
76-year-old woman presented with a 3-year history of blister 
formation. Physical examination revealed pruritic erythemas 
with vesicles on the trunk and legs, but no lesions of the oral 
mucosa. A skin biopsy specimen revealed intraepidermal 
blister containing neutrophils, eosinophils, and lymphocytes. 
Direct immunofluorescence (IF) showed immunoglobulin G 
(IgG) and complement 3 (C3) depositions on the keratinocyte 
cell surfaces. Indirect IF showed IgG anti-keratinocyte cell 
surface antibodies. These findings hinted at a diagnosis of 
pemphigus. However, repeated enzyme-linked immuno-
sorbent assays (ELISAs) for both anti-Dsg1 and 3 antibodies 
proved to be negative. Immunoblotting of normal human ep-
idermal extracts revealed Dsc antibodies, and recently estab-
lished ELISAs using human Dsc1-Dsc3 recombinantly ex-
pressed in mammalian cells detected anti-Dsc3 antibodies. 
Based on these clinical, histopathological, and immuno-
logical findings, the patient was diagnosed as PH with only 
anti-Dsc3 antibodies. Treatment with corticosteroid pre-
dnisolone and steroid-sparing agent dapsone accomplished 
complete clinical remission of the patient. (Ann Dermatol 
28(1) 102∼106, 2016)
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INTRODUCTION
Pemphigus represents a group of autoimmune blistering 
diseases caused by autoantibodies against desmogleins 
(Dsgs), a class of the cell surface adhesion proteins, des-
mosomal cadherins1. In humans, 7 desmosomal cadher-
ins, 4 desmogleins (Dsg1–4) and 3 desmocollins, (Dsc1–
3), have been described. Pemphigus can be divided into 
two major forms: pemphigus foliaceus (PF) and pemphi-
gus vulgaris (PV). In PF, autoantibodies against Dsg1 cause 
blisters on the superficial epidermis. In mucosal dominant 
PV, autoantibodies against Dsg3 cause blisters on the su-
prabasal layer of the mucous membrane. In mucocuta-
neous PV, autoantibodies against both Dsg3 and Dsg1 
cause suprabasilar blisters on the skin and mucous mem-
branes. Pemphigus herpetiformis (PH) is a rare variant of 
pemphigus that clinically resembles dermatitis herpeti-
formis but shows immunopathological features of pem-
phigus. PH exhibits IgG autoantibodies against Dsg1 in 
most cases and against Dsg3 in the remainder2. 
Recently, several pemphigus patients only with Dsc3-specific 
antibodies have been reported3-6. Here we report a case of 
PH, which evinced anti-Dsc3-specific antibodies but not 
anti-Dsg antibodies.
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Fig. 1. Clinical and histopathologic 
findings. Clinical features. Annular 
erythematous plaques with grouped 
peripheral tense vesicobullae on 
the (A) trunk and (B) legs. (C) His-
topathological features. Intraepider-
mal blister with infiltrates of neu-
trophils, eosinophils and lympho-
cytes (H&E, ×200).
CASE REPORT
A 76-year-old woman presented with a 3-year history of 
blister formation but no history of malignancy or auto-
immune disease. Physical examination revealed annular 
erythematous plaques with grouped peripheral vesicobullae 
with intensive itch on the trunk and legs (Fig. 1A, B). Oral 
mucosa was not affected. A skin biopsy specimen re-
vealed intraepidermal blister containing neutrophils, eosi-
nophils and lymphocytes (Fig. 1C). In the dermis, infiltra-
tion of lymphocytes and eosinophils was seen. Direct im-
munofluorescence (IF) study showed IgG and complement 
3 (C3) depositions on keratinocyte cell surfaces (Fig. 2A, 
B). Indirect IF of normal human skin also revealed IgG an-
ti-keratinocyte cell surface antibodies. 
These findings suspected the diagnosis of pemphigus. 
However, repeated enzyme-linked immunosorbent assay 
(ELISA) for both anti-Dsg1 and 3 antibodies showed neg-
ative results. Immunoblotting with normal human epi-
dermal extracts revealed a doublet of a-form (110-kDa) 
and b-form (100-kDa) Dscs (Fig. 2C). Finally, recently es-
tablished ELISAs using recombinantly expressed human 
Dsc1-Dsc37 proteins in mammalian cells detected an-
ti-Dsc3 (OD 2.263, cut-off ＞0.120) antibodies, but no an-
tibodies for Dsc1 (OD 0.166, cut-off ＞0.200) and 2 (OD 
0.015, cut-off ＞0.070). 
Based on these clinical, histopathological and immuno-
logical findings, the patient was diagnosed as PH ex-
clusively with anti-Dsc3 antibodies. The skin lesions re-
sponded well with oral methylprednisolone (4∼12 mg/day) 
and dapsone (50 mg/day), and the patient achieved com-
plete remission 4 months after the initiation of the 
treatment.
DISCUSSION
Desmosomes in keratinocytes are the most important in-
tercellular adhering junctions that provide structural 
strength to the epidermis. Dsg3 and Dsc3 are the predom-
inant isoforms expressed in the basal epidermis, the site of 
blister formation in pemphigus vulgaris. Dsg1 and Dsc1 
are expressed in an inverse pattern, predominantly in the 
superficial epidermis with little to no expression in the 
basal layers. Although the major autoantigens for pemphi-
gus are Dsgs, several studies have reported that Dsc3 ho-
mo- and heterophilic binding is required to maintain kera-
tinocyte cohesion and interference with Dsc3 multi-
merization may contribute to skin blistering in pemphi-
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Fig. 2. Immunologcal findings. DIF shows (A) immunoglobulin G (IgG) and (B) complement 3 (C3) deposition along the cell surface 
of keratinocytes. (C) Results of immunoblotting of normal human epidermal extracts. Pemphigus vulgaris (PV) control serum reacted 
with the 160-kDa desmoglein (Dsg) 1 and the 130-kDa Dsg3 (lane 1), paraneoplastic pemphigus (PNP) control serum reacted with 
the 210-kDa envoplakin and the 190-kDa periplakin (lane 2), bullous pemphigoid (BP) control serum reacted with the 230-kDa BP230 
and the 180-kDa BP180 (lane 3), anti-desmocollin (Dsc) monoclonal antibody (mAb) (lane 4) and the patient serum (lane 5) reacted 
strongly with the 110-kDa a-form and the 100-kDa b-form Dsc3. DIF: direct immunofluorescence.
gus5,8. 
In our literature survey, we reviewed twenty-one cases of 
pemphigus with IgG anti-Dsc3 autoantibodies (Table 1). 
We found 1 case with autoantibodies exclusively against 
Dsc3 showing PV-like clinical and histopathological phe-
notypes, suggesting that Dsc3 and Dsg3 interact and have 
similar function in the lower epidermis3. In contrast, most 
other cases were those of atypical pemphigus, such as PH, 
paraneoplastic pemphigus and pemphigus vegetans, in-
dicating that the pathogenic role of anti-Dsc3 antibodies is 
distinct from antibodies to either Dsg1 or Dsg3. These 
findings are consistent with the results of a recent study, 
which showed that sera from 30%∼40% of patients with 
PH and pemphigus vegetans showed reactivity with 
Dsc1-Dsc3, and in contrast sera from only a few patients 
with PV and PF showed anti-Dsc antibodies at low titer7. 
Among the 20 cases with description of oral involvement, 
nine cases had mucosal lesions, suggesting that an-
ti-Dsc3 antibodies are responsible for oral mucosal le-
sions (Table 1)9-20. This result is contradictory to the re-
sults in Dsc3-knock-out mice, which showed blisters on 
the skin but no mucosal lesions8. This discrepancy may be 
explained by the fact that high expression levels of Dsc2 
compensated for the loss of Dsc3 in mucous membranes 
of mice.
Our patient had clinical and histopathologic features of 
PH, but ELISAs for both Dsg1 and Dsg3 showed negative 
results. In contrast, immunoblotting of normal epidermal 
extract showed strong reactivity with Dscs, and novel 
ELISAs for Dsc1-Dsc3 detected only anti-Dsc3 antibodies. 
Favorable responses to low-dose steroid and dapsone in 
this patient may indicate milder pathogenic activity of an-
ti-Dsc3 than anti-Dsg3 antibodies, which was also sug-
gested in a previous study3. Taken together, these results 
strongly indicate that this is a case of pemphigus herpeti-
formis and IgG anti-Dsc3 antibodies play an important 
role in pemphigus pathogenesis.
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Table 1. Reported cases of autoimmune blistering disease in association with Dsc3-specific immunoglobulin G antibodies
Case Sex Age (yr) Diagnosis Mucosal lesions Autoantibodies Reference No.
 1 M 42 PH − Dsc3, Dsg1 9
 2 F 11 Atypical pemphigus + Dsc3, Dsg3, Desmoplakin 10
 3 F 48 PNP + Dsc3, Dsc2, Dsg3,
Envoplakin/periplakin, BP180
11
 4 M 63 BP+pemphigus vegetans − Dsc3, BP230, BP180 12
 5 ND ND PNP ND Dsc3, Dsg3 13
 6 M 53 Pemphigus+gastric carcinoma − Dsc3, Dsc1, Dsc2 14
 7 F 55 PV + Dsc3 3
 8 ND ND Pemphigus vegetans + Dsc3 4
 9 ND ND Pemphigus vegetans − Dsc3, Dsg1 4
10 ND ND PH + Dsc3 4
11 ND ND PH − Dsc3 4
12 F 79 Atypical pemphigus − Dsc3 5
13 F 83 BP+PH + Dsc3, Dsc2, Dsc1, Dsg1, Dsg3
BP180
15
14 F 81 PNP+follicular B cell lymphoma + Dsc3, Dsc2, Dsg3
Periplakin
16
15 M 54 PV+SCC + Dsc3, Dsc 1, Dsc2, 
Dsg1, Dsg3
17
16 F 84 PH − Dsc3, Dsg1 18
17 F 80s Pemphigus vegetans − Dsc3, Dsg1 19
18 F 70s Pemphigus vegetans − Dsc3
BP230, Periplakin
19
19 M 68 Herpetiform bullous dermatosis + Dsc3, Dsc1
LAD-1
20
20 M 57 PH − Dsc3 6
21 F 76 PH − Dsc3 Present case
Dsc: desmocollin, M: male, F: female, PH: pemphigus herpetiformis, Dsg: desmoglein, BP: bullous pemphigoid, PNP: paraneoplastic
pemphigus, SCC: squamous cell carcinoma, PV: pemphigus vulgaris, LAD-1: linear IgA dermatosis antigen, ND: no description. 
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